Cargando…
IL-23 Monoclonal Antibodies for IBD: So Many, So Different?
Interleukin [IL]-23 is a member of the IL-12 family of cytokines and has been implicated in multiple inflammatory disorders including psoriasis, psoriatic arthritis, and the inflammatory bowel diseases [IBDs]. Blockade of both IL-12 and IL-23 using an antibody that targets a shared subunit is highly...
Autores principales: | McDonald, Benjamin D, Dyer, Emma C, Rubin, David T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097671/ https://www.ncbi.nlm.nih.gov/pubmed/35553664 http://dx.doi.org/10.1093/ecco-jcc/jjac038 |
Ejemplares similares
-
Why are there so few (or so many) circulating coronaviruses?
por: Rice, Benjamin L., et al.
Publicado: (2021) -
The management of neuropsychiatric lupus in the 21st century: still so many unmet needs?
por: Govoni, Marcello, et al.
Publicado: (2020) -
What Can IBD Specialists Learn from IL-23 Trials in Dermatology?
por: Valenti, Mario, et al.
Publicado: (2022) -
If so many are “few,” how few are “many”?
por: Heim, Stefan, et al.
Publicado: (2015) -
IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality
por: Atreya, Raja, et al.
Publicado: (2022)